|
SPRED2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64430002946858E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.35260041950391E-10 |
| Normal-vs-Stage2 |
9.86410000014537E-07 |
| Normal-vs-Stage3 |
1.693550E-02 |
| Normal-vs-Stage4 |
1.305000E-01 |
| Stage1-vs-Stage2 |
8.469000E-01 |
| Stage1-vs-Stage3 |
3.584200E-02 |
| Stage1-vs-Stage4 |
1.852420E-01 |
| Stage2-vs-Stage3 |
1.216810E-01 |
| Stage2-vs-Stage4 |
2.273400E-01 |
| Stage3-vs-Stage4 |
9.570000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.91620008328198E-10 |
| Normal-vs-AfricanAmerican |
9.00900000155858E-08 |
| Normal-vs-Asian |
1.015550E-03 |
| Caucasian-vs-AfricanAmerican |
8.595000E-01 |
| Caucasian-vs-Asian |
8.259200E-01 |
| AfricanAmerican-vs-Asian |
7.721000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.24713605898341E-12 |
| Normal-vs-Female |
8.903100E-03 |
| Male-vs-Female |
6.46899999999784E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.19339999999457E-05 |
| Normal-vs-Extreme_Weight |
4.90320006818479E-11 |
| Normal-vs-Obese |
1.842620E-04 |
| Normal-vs-Extreme_Obese |
2.52430000002857E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.551000E-01 |
| Normal_Weight-vs-Obese |
4.606000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.178200E-01 |
| Extreme_Weight-vs-Obese |
1.444070E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.403200E-01 |
| Obese-vs-Extreme_Obese |
1.703840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.698800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.01660000207238E-08 |
| Normal-vs-Age(61-80Yrs) |
6.83529899347946E-11 |
| Normal-vs-Age(81-100Yrs) |
6.27989882318047E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.525900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.902100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.860100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.013700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.282640E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.680200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.29445368155257E-12 |
| Normal-VS-Type2 PRCC |
3.77669999718222E-08 |
| Normal-VS-KIRP CIMP |
5.722300E-02 |
| Normal-VS-Unclassified PRCC |
1.16729999999343E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.401820E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.822400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.636160E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.202460E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.148200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.622620E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.54765089632747E-13 |
| Normal-vs-N1 |
4.744200E-01 |
| Normal-vs-N2 |
6.496000E-01 |
| N0-vs-N1 |
7.020900E-04 |
| N0-vs-N2 |
2.599500E-03 |
| N1-vs-N2 |
9.573000E-01 |
|
|
